nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—SLC22A2—Metformin—polycystic ovary syndrome	0.273	0.535	CbGbCtD
Cytarabine—SLC22A1—Metformin—polycystic ovary syndrome	0.237	0.465	CbGbCtD
Cytarabine—POLB—pituitary gland—polycystic ovary syndrome	0.00594	0.0235	CbGeAlD
Cytarabine—DCTD—adrenal cortex—polycystic ovary syndrome	0.00592	0.0235	CbGeAlD
Cytarabine—POLB—adipose tissue—polycystic ovary syndrome	0.00591	0.0234	CbGeAlD
Cytarabine—NT5E—embryo—polycystic ovary syndrome	0.00559	0.0221	CbGeAlD
Cytarabine—POLE—embryo—polycystic ovary syndrome	0.00548	0.0217	CbGeAlD
Cytarabine—POLB—adrenal gland—polycystic ovary syndrome	0.0053	0.021	CbGeAlD
Cytarabine—DCTD—endometrium—polycystic ovary syndrome	0.00529	0.0209	CbGeAlD
Cytarabine—POLB—female gonad—polycystic ovary syndrome	0.00495	0.0196	CbGeAlD
Cytarabine—POLD1—uterus—polycystic ovary syndrome	0.00494	0.0196	CbGeAlD
Cytarabine—POLB—vagina—polycystic ovary syndrome	0.00492	0.0195	CbGeAlD
Cytarabine—DCTD—uterus—polycystic ovary syndrome	0.00487	0.0193	CbGeAlD
Cytarabine—POLD1—adipose tissue—polycystic ovary syndrome	0.00483	0.0191	CbGeAlD
Cytarabine—CDA—endometrium—polycystic ovary syndrome	0.00481	0.0191	CbGeAlD
Cytarabine—DCTD—pituitary gland—polycystic ovary syndrome	0.00479	0.019	CbGeAlD
Cytarabine—DCTD—adipose tissue—polycystic ovary syndrome	0.00477	0.0189	CbGeAlD
Cytarabine—POLB—endocrine gland—polycystic ovary syndrome	0.0046	0.0182	CbGeAlD
Cytarabine—CDA—adipose tissue—polycystic ovary syndrome	0.00434	0.0172	CbGeAlD
Cytarabine—POLD1—adrenal gland—polycystic ovary syndrome	0.00433	0.0172	CbGeAlD
Cytarabine—DCTD—adrenal gland—polycystic ovary syndrome	0.00428	0.0169	CbGeAlD
Cytarabine—Clofarabine—RRM2—polycystic ovary syndrome	0.0042	0.522	CrCbGaD
Cytarabine—NT5E—endometrium—polycystic ovary syndrome	0.00409	0.0162	CbGeAlD
Cytarabine—POLD1—female gonad—polycystic ovary syndrome	0.00404	0.016	CbGeAlD
Cytarabine—POLE—endometrium—polycystic ovary syndrome	0.00401	0.0159	CbGeAlD
Cytarabine—DCTD—female gonad—polycystic ovary syndrome	0.00399	0.0158	CbGeAlD
Cytarabine—DCTD—vagina—polycystic ovary syndrome	0.00396	0.0157	CbGeAlD
Cytarabine—CDA—adrenal gland—polycystic ovary syndrome	0.00389	0.0154	CbGeAlD
Cytarabine—Gemcitabine—RRM2—polycystic ovary syndrome	0.00384	0.478	CrCbGaD
Cytarabine—NT5E—uterus—polycystic ovary syndrome	0.00377	0.0149	CbGeAlD
Cytarabine—DCTD—endocrine gland—polycystic ovary syndrome	0.00371	0.0147	CbGeAlD
Cytarabine—NT5E—pituitary gland—polycystic ovary syndrome	0.0037	0.0147	CbGeAlD
Cytarabine—NT5E—adipose tissue—polycystic ovary syndrome	0.00369	0.0146	CbGeAlD
Cytarabine—POLE—pituitary gland—polycystic ovary syndrome	0.00363	0.0144	CbGeAlD
Cytarabine—POLE—adipose tissue—polycystic ovary syndrome	0.00361	0.0143	CbGeAlD
Cytarabine—CDA—vagina—polycystic ovary syndrome	0.0036	0.0143	CbGeAlD
Cytarabine—CYP3A4—urine—polycystic ovary syndrome	0.0035	0.0139	CbGeAlD
Cytarabine—POLA1—endometrium—polycystic ovary syndrome	0.00345	0.0137	CbGeAlD
Cytarabine—CDA—endocrine gland—polycystic ovary syndrome	0.00337	0.0134	CbGeAlD
Cytarabine—NT5E—adrenal gland—polycystic ovary syndrome	0.00331	0.0131	CbGeAlD
Cytarabine—POLE—adrenal gland—polycystic ovary syndrome	0.00324	0.0128	CbGeAlD
Cytarabine—POLA1—pituitary gland—polycystic ovary syndrome	0.00313	0.0124	CbGeAlD
Cytarabine—POLA1—adipose tissue—polycystic ovary syndrome	0.00311	0.0123	CbGeAlD
Cytarabine—NT5E—female gonad—polycystic ovary syndrome	0.00308	0.0122	CbGeAlD
Cytarabine—NT5E—vagina—polycystic ovary syndrome	0.00306	0.0121	CbGeAlD
Cytarabine—POLE—female gonad—polycystic ovary syndrome	0.00302	0.012	CbGeAlD
Cytarabine—POLE—vagina—polycystic ovary syndrome	0.003	0.0119	CbGeAlD
Cytarabine—DCK—embryo—polycystic ovary syndrome	0.00291	0.0115	CbGeAlD
Cytarabine—NT5E—endocrine gland—polycystic ovary syndrome	0.00287	0.0114	CbGeAlD
Cytarabine—POLE—endocrine gland—polycystic ovary syndrome	0.00281	0.0111	CbGeAlD
Cytarabine—POLA1—adrenal gland—polycystic ovary syndrome	0.00279	0.0111	CbGeAlD
Cytarabine—POLA1—female gonad—polycystic ovary syndrome	0.0026	0.0103	CbGeAlD
Cytarabine—POLA1—vagina—polycystic ovary syndrome	0.00259	0.0103	CbGeAlD
Cytarabine—SLC29A1—adrenal cortex—polycystic ovary syndrome	0.0025	0.00989	CbGeAlD
Cytarabine—DCK—adrenal cortex—polycystic ovary syndrome	0.00239	0.00945	CbGeAlD
Cytarabine—ABCC10—adrenal cortex—polycystic ovary syndrome	0.00227	0.009	CbGeAlD
Cytarabine—SLC29A1—endometrium—polycystic ovary syndrome	0.00223	0.00883	CbGeAlD
Cytarabine—DCK—endometrium—polycystic ovary syndrome	0.00213	0.00844	CbGeAlD
Cytarabine—SLC29A1—uterus—polycystic ovary syndrome	0.00205	0.00814	CbGeAlD
Cytarabine—ABCC10—endometrium—polycystic ovary syndrome	0.00203	0.00804	CbGeAlD
Cytarabine—SLC29A1—pituitary gland—polycystic ovary syndrome	0.00202	0.00799	CbGeAlD
Cytarabine—SLC29A1—adipose tissue—polycystic ovary syndrome	0.00201	0.00796	CbGeAlD
Cytarabine—DCK—uterus—polycystic ovary syndrome	0.00196	0.00777	CbGeAlD
Cytarabine—DCK—pituitary gland—polycystic ovary syndrome	0.00193	0.00763	CbGeAlD
Cytarabine—DCK—adipose tissue—polycystic ovary syndrome	0.00192	0.0076	CbGeAlD
Cytarabine—ABCC10—uterus—polycystic ovary syndrome	0.00187	0.00741	CbGeAlD
Cytarabine—ABCC10—pituitary gland—polycystic ovary syndrome	0.00184	0.00727	CbGeAlD
Cytarabine—ABCC10—adipose tissue—polycystic ovary syndrome	0.00183	0.00724	CbGeAlD
Cytarabine—SLC29A1—adrenal gland—polycystic ovary syndrome	0.0018	0.00714	CbGeAlD
Cytarabine—DCK—adrenal gland—polycystic ovary syndrome	0.00172	0.00682	CbGeAlD
Cytarabine—SLC29A1—female gonad—polycystic ovary syndrome	0.00168	0.00666	CbGeAlD
Cytarabine—SLC29A1—vagina—polycystic ovary syndrome	0.00167	0.00662	CbGeAlD
Cytarabine—ABCC10—adrenal gland—polycystic ovary syndrome	0.00164	0.0065	CbGeAlD
Cytarabine—SLC22A1—adipose tissue—polycystic ovary syndrome	0.00164	0.00648	CbGeAlD
Cytarabine—DCK—female gonad—polycystic ovary syndrome	0.00161	0.00636	CbGeAlD
Cytarabine—DCK—vagina—polycystic ovary syndrome	0.0016	0.00632	CbGeAlD
Cytarabine—SLC29A1—endocrine gland—polycystic ovary syndrome	0.00156	0.00619	CbGeAlD
Cytarabine—ABCC10—female gonad—polycystic ovary syndrome	0.00153	0.00606	CbGeAlD
Cytarabine—ABCC10—vagina—polycystic ovary syndrome	0.00152	0.00602	CbGeAlD
Cytarabine—DCK—endocrine gland—polycystic ovary syndrome	0.00149	0.00591	CbGeAlD
Cytarabine—ABCC10—endocrine gland—polycystic ovary syndrome	0.00142	0.00563	CbGeAlD
Cytarabine—SLC22A1—vagina—polycystic ovary syndrome	0.00136	0.00539	CbGeAlD
Cytarabine—SLC22A1—endocrine gland—polycystic ovary syndrome	0.00127	0.00504	CbGeAlD
Cytarabine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00058	0.0023	CbGeAlD
Cytarabine—POLD1—Cell Cycle—CCNB1—polycystic ovary syndrome	0.000191	0.000834	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—RRM2—polycystic ovary syndrome	0.000191	0.000833	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—NCOR1—polycystic ovary syndrome	0.00019	0.00083	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000185	0.000807	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CCNB1—polycystic ovary syndrome	0.000185	0.000805	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—YAP1—polycystic ovary syndrome	0.000184	0.000803	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—MAD2L1—polycystic ovary syndrome	0.000183	0.000799	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000183	0.000799	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000181	0.000788	CbGpPWpGaD
Cytarabine—CDA—Metabolism—SULT2A1—polycystic ovary syndrome	0.000181	0.000787	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—CYP1A1—polycystic ovary syndrome	0.000181	0.000787	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000179	0.000781	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—NAMPT—polycystic ovary syndrome	0.000177	0.000771	CbGpPWpGaD
Cytarabine—CDA—Metabolism—RRM2—polycystic ovary syndrome	0.000175	0.000762	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CYP11A1—polycystic ovary syndrome	0.000175	0.000762	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000174	0.000758	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000174	0.000757	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—RRM2—polycystic ovary syndrome	0.000174	0.000757	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PNPLA2—polycystic ovary syndrome	0.000172	0.000751	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	0.000171	0.000743	CbGpPWpGaD
Cytarabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000169	0.000736	CbGpPWpGaD
Cytarabine—CDA—Metabolism—YAP1—polycystic ovary syndrome	0.000169	0.000734	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000169	0.000734	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—MTHFR—polycystic ovary syndrome	0.000168	0.000733	CbGpPWpGaD
Cytarabine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000167	0.000726	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—STAR—polycystic ovary syndrome	0.000166	0.000722	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—AKR1C3—polycystic ovary syndrome	0.000165	0.000719	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MAD2L1—polycystic ovary syndrome	0.000164	0.000715	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—TOP2A—polycystic ovary syndrome	0.000164	0.000712	CbGpPWpGaD
Cytarabine—DCK—Metabolism—SRD5A1—polycystic ovary syndrome	0.000163	0.000712	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CYP17A1—polycystic ovary syndrome	0.000163	0.000708	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000162	0.000706	CbGpPWpGaD
Cytarabine—CDA—Metabolism—NAMPT—polycystic ovary syndrome	0.000162	0.000705	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CYP11A1—polycystic ovary syndrome	0.00016	0.000697	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00016	0.000697	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000158	0.000689	CbGpPWpGaD
Cytarabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000157	0.000684	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000156	0.00068	CbGpPWpGaD
Cytarabine—DCK—Metabolism—STAR—polycystic ovary syndrome	0.000156	0.000679	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000155	0.000677	CbGpPWpGaD
Cytarabine—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000155	0.000675	CbGpPWpGaD
Cytarabine—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000154	0.000669	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—LMNA—polycystic ovary syndrome	0.000153	0.000664	CbGpPWpGaD
Cytarabine—CDA—Metabolism—AKR1C3—polycystic ovary syndrome	0.000151	0.000658	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000149	0.000649	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CYP17A1—polycystic ovary syndrome	0.000149	0.000648	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—HMMR—polycystic ovary syndrome	0.000148	0.000644	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	0.000147	0.000642	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TOP2A—polycystic ovary syndrome	0.000146	0.000637	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000141	0.000614	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—TH—polycystic ovary syndrome	0.000141	0.000613	CbGpPWpGaD
Cytarabine—DCK—Metabolism—HMMR—polycystic ovary syndrome	0.000139	0.000605	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000139	0.000604	CbGpPWpGaD
Cytarabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000137	0.000596	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—SLC2A4—polycystic ovary syndrome	0.000137	0.000596	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PPARG—polycystic ovary syndrome	0.000136	0.000595	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000136	0.000594	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—POMC—polycystic ovary syndrome	0.000135	0.000586	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—INS—polycystic ovary syndrome	0.000134	0.000583	CbGpPWpGaD
Cytarabine—DCK—Metabolism—HSD3B1—polycystic ovary syndrome	0.000133	0.000577	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CCNB1—polycystic ovary syndrome	0.000132	0.000574	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000129	0.000563	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CYP19A1—polycystic ovary syndrome	0.000129	0.00056	CbGpPWpGaD
Cytarabine—CDA—Metabolism—TH—polycystic ovary syndrome	0.000129	0.00056	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—LHB—polycystic ovary syndrome	0.000129	0.00056	CbGpPWpGaD
Cytarabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000127	0.000554	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000126	0.000547	CbGpPWpGaD
Cytarabine—CDA—Metabolism—SLC2A4—polycystic ovary syndrome	0.000125	0.000545	CbGpPWpGaD
Cytarabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000124	0.000541	CbGpPWpGaD
Cytarabine—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000124	0.000539	CbGpPWpGaD
Cytarabine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000123	0.000534	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—DLG4—polycystic ovary syndrome	0.000122	0.000534	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000122	0.00053	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000121	0.000529	CbGpPWpGaD
Cytarabine—DCK—Metabolism—LHB—polycystic ovary syndrome	0.000121	0.000527	CbGpPWpGaD
Cytarabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000119	0.000519	CbGpPWpGaD
Cytarabine—DCK—Metabolism—HSD3B2—polycystic ovary syndrome	0.000118	0.000515	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CYP19A1—polycystic ovary syndrome	0.000118	0.000513	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—GNAS—polycystic ovary syndrome	0.000115	0.0005	CbGpPWpGaD
Cytarabine—DCK—Metabolism—AKR1C1—polycystic ovary syndrome	0.000114	0.000498	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—DLG4—polycystic ovary syndrome	0.000114	0.000497	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000113	0.000493	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000113	0.000491	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000112	0.000488	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—NCOR1—polycystic ovary syndrome	0.000109	0.000477	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—RRM2—polycystic ovary syndrome	0.000108	0.000473	CbGpPWpGaD
Cytarabine—DCK—Metabolism—SULT2A1—polycystic ovary syndrome	0.000105	0.000459	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000105	0.000458	CbGpPWpGaD
Cytarabine—CDA—Metabolism—GNAS—polycystic ovary syndrome	0.000105	0.000458	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—YAP1—polycystic ovary syndrome	0.000105	0.000455	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CYP1A1—polycystic ovary syndrome	0.000104	0.000452	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000103	0.000449	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SUOX—polycystic ovary syndrome	0.000103	0.000449	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000102	0.000444	CbGpPWpGaD
Cytarabine—DCK—Metabolism—RRM2—polycystic ovary syndrome	0.000102	0.000444	CbGpPWpGaD
Cytarabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000101	0.000439	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—NAMPT—polycystic ovary syndrome	0.0001	0.000438	CbGpPWpGaD
Cytarabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.0001	0.000436	CbGpPWpGaD
Cytarabine—CDA—Metabolism—NCOR1—polycystic ovary syndrome	0.0001	0.000436	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CYP11A1—polycystic ovary syndrome	9.92e-05	0.000432	CbGpPWpGaD
Cytarabine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	9.88e-05	0.00043	CbGpPWpGaD
Cytarabine—DCK—Metabolism—YAP1—polycystic ovary syndrome	9.83e-05	0.000428	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—MTHFR—polycystic ovary syndrome	9.67e-05	0.000421	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—LPCAT2—polycystic ovary syndrome	9.6e-05	0.000418	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SUOX—polycystic ovary syndrome	9.6e-05	0.000418	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ISYNA1—polycystic ovary syndrome	9.58e-05	0.000417	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CYP1A1—polycystic ovary syndrome	9.48e-05	0.000413	CbGpPWpGaD
Cytarabine—DCK—Metabolism—NAMPT—polycystic ovary syndrome	9.44e-05	0.000411	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—AKR1C3—polycystic ovary syndrome	9.37e-05	0.000408	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CYP11A1—polycystic ovary syndrome	9.33e-05	0.000406	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CYP17A1—polycystic ovary syndrome	9.22e-05	0.000402	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ISYNA1—polycystic ovary syndrome	8.93e-05	0.000389	CbGpPWpGaD
Cytarabine—CDA—Metabolism—MTHFR—polycystic ovary syndrome	8.84e-05	0.000385	CbGpPWpGaD
Cytarabine—DCK—Metabolism—AKR1C3—polycystic ovary syndrome	8.81e-05	0.000384	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	8.8e-05	0.000383	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CYP17A1—polycystic ovary syndrome	8.67e-05	0.000378	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	8.21e-05	0.000358	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—TEAD2—polycystic ovary syndrome	8.15e-05	0.000355	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—AKR1C2—polycystic ovary syndrome	8.15e-05	0.000355	CbGpPWpGaD
Cytarabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	8.12e-05	0.000354	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	8.09e-05	0.000353	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—TH—polycystic ovary syndrome	7.98e-05	0.000348	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PPARG—polycystic ovary syndrome	7.84e-05	0.000342	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—SLC2A4—polycystic ovary syndrome	7.76e-05	0.000338	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—POMC—polycystic ovary syndrome	7.73e-05	0.000337	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—INS—polycystic ovary syndrome	7.69e-05	0.000335	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—TEAD2—polycystic ovary syndrome	7.59e-05	0.000331	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—AKR1C2—polycystic ovary syndrome	7.59e-05	0.000331	CbGpPWpGaD
Cytarabine—DCK—Metabolism—TH—polycystic ovary syndrome	7.5e-05	0.000327	CbGpPWpGaD
Cytarabine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	7.46e-05	0.000325	CbGpPWpGaD
Cytarabine—DCK—Metabolism—SLC2A4—polycystic ovary syndrome	7.3e-05	0.000318	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CYP19A1—polycystic ovary syndrome	7.3e-05	0.000318	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	7.27e-05	0.000317	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	7.26e-05	0.000316	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	7.17e-05	0.000312	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PPARG—polycystic ovary syndrome	7.17e-05	0.000312	CbGpPWpGaD
Cytarabine—CDA—Metabolism—POMC—polycystic ovary syndrome	7.07e-05	0.000308	CbGpPWpGaD
Cytarabine—CDA—Metabolism—INS—polycystic ovary syndrome	7.03e-05	0.000306	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CYP19A1—polycystic ovary syndrome	6.86e-05	0.000299	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PNPLA2—polycystic ovary syndrome	6.83e-05	0.000297	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	6.77e-05	0.000295	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	6.76e-05	0.000295	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	6.76e-05	0.000294	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	6.75e-05	0.000294	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	6.67e-05	0.00029	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GNAS—polycystic ovary syndrome	6.51e-05	0.000284	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SRD5A1—polycystic ovary syndrome	6.47e-05	0.000282	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PNPLA2—polycystic ovary syndrome	6.36e-05	0.000277	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	6.29e-05	0.000274	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—NCOR1—polycystic ovary syndrome	6.21e-05	0.00027	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—STAR—polycystic ovary syndrome	6.17e-05	0.000269	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	6.17e-05	0.000269	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GNAS—polycystic ovary syndrome	6.12e-05	0.000267	CbGpPWpGaD
Cytarabine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	6.05e-05	0.000264	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SRD5A1—polycystic ovary syndrome	6.03e-05	0.000263	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CYP1A1—polycystic ovary syndrome	5.88e-05	0.000256	CbGpPWpGaD
Cytarabine—DCK—Metabolism—NCOR1—polycystic ovary syndrome	5.83e-05	0.000254	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—STAR—polycystic ovary syndrome	5.75e-05	0.000251	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	5.75e-05	0.000251	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CYP1A1—polycystic ovary syndrome	5.53e-05	0.000241	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—HMMR—polycystic ovary syndrome	5.5e-05	0.00024	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—MTHFR—polycystic ovary syndrome	5.48e-05	0.000239	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	5.35e-05	0.000233	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	5.27e-05	0.00023	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—HSD3B1—polycystic ovary syndrome	5.25e-05	0.000229	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	5.18e-05	0.000226	CbGpPWpGaD
Cytarabine—DCK—Metabolism—MTHFR—polycystic ovary syndrome	5.16e-05	0.000225	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—HMMR—polycystic ovary syndrome	5.13e-05	0.000223	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—HSD3B1—polycystic ovary syndrome	4.89e-05	0.000213	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.83e-05	0.00021	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—LHB—polycystic ovary syndrome	4.79e-05	0.000209	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—HSD3B2—polycystic ovary syndrome	4.68e-05	0.000204	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—AKR1C1—polycystic ovary syndrome	4.53e-05	0.000197	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—LHB—polycystic ovary syndrome	4.46e-05	0.000194	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PPARG—polycystic ovary syndrome	4.45e-05	0.000194	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—POMC—polycystic ovary syndrome	4.39e-05	0.000191	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—INS—polycystic ovary syndrome	4.36e-05	0.00019	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—HSD3B2—polycystic ovary syndrome	4.36e-05	0.00019	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	4.31e-05	0.000188	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	4.25e-05	0.000185	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—AKR1C1—polycystic ovary syndrome	4.22e-05	0.000184	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PPARG—polycystic ovary syndrome	4.18e-05	0.000182	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SULT2A1—polycystic ovary syndrome	4.17e-05	0.000182	CbGpPWpGaD
Cytarabine—DCK—Metabolism—POMC—polycystic ovary syndrome	4.12e-05	0.00018	CbGpPWpGaD
Cytarabine—DCK—Metabolism—INS—polycystic ovary syndrome	4.1e-05	0.000179	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—RRM2—polycystic ovary syndrome	4.04e-05	0.000176	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—YAP1—polycystic ovary syndrome	3.89e-05	0.00017	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SULT2A1—polycystic ovary syndrome	3.89e-05	0.000169	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	3.79e-05	0.000165	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—RRM2—polycystic ovary syndrome	3.76e-05	0.000164	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NAMPT—polycystic ovary syndrome	3.74e-05	0.000163	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYP11A1—polycystic ovary syndrome	3.69e-05	0.000161	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—YAP1—polycystic ovary syndrome	3.63e-05	0.000158	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—AKR1C3—polycystic ovary syndrome	3.49e-05	0.000152	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NAMPT—polycystic ovary syndrome	3.49e-05	0.000152	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	3.47e-05	0.000151	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	3.47e-05	0.000151	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYP11A1—polycystic ovary syndrome	3.44e-05	0.00015	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYP17A1—polycystic ovary syndrome	3.43e-05	0.00015	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—AKR1C3—polycystic ovary syndrome	3.25e-05	0.000142	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	3.22e-05	0.00014	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	3.21e-05	0.00014	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYP17A1—polycystic ovary syndrome	3.2e-05	0.000139	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—TH—polycystic ovary syndrome	2.97e-05	0.000129	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SLC2A4—polycystic ovary syndrome	2.89e-05	0.000126	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—TH—polycystic ovary syndrome	2.77e-05	0.000121	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	2.74e-05	0.000119	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	2.74e-05	0.000119	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYP19A1—polycystic ovary syndrome	2.72e-05	0.000118	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SLC2A4—polycystic ovary syndrome	2.69e-05	0.000117	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYP19A1—polycystic ovary syndrome	2.53e-05	0.00011	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GNAS—polycystic ovary syndrome	2.43e-05	0.000106	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NCOR1—polycystic ovary syndrome	2.31e-05	0.000101	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	2.3e-05	0.0001	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GNAS—polycystic ovary syndrome	2.26e-05	9.85e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYP1A1—polycystic ovary syndrome	2.19e-05	9.54e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	2.18e-05	9.49e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NCOR1—polycystic ovary syndrome	2.15e-05	9.38e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	2.08e-05	9.05e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—MTHFR—polycystic ovary syndrome	2.04e-05	8.9e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYP1A1—polycystic ovary syndrome	2.04e-05	8.9e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—MTHFR—polycystic ovary syndrome	1.9e-05	8.29e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.85e-05	8.07e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.77e-05	7.7e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PPARG—polycystic ovary syndrome	1.66e-05	7.21e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—POMC—polycystic ovary syndrome	1.63e-05	7.12e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—INS—polycystic ovary syndrome	1.62e-05	7.08e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.61e-05	7.02e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.57e-05	6.86e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	1.54e-05	6.72e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.53e-05	6.64e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	1.52e-05	6.63e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—INS—polycystic ovary syndrome	1.51e-05	6.6e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.4e-05	6.11e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.36e-05	5.92e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.31e-05	5.71e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.26e-05	5.48e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.24e-05	5.42e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.17e-05	5.12e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.16e-05	5.04e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1e-05	4.36e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	9.73e-06	4.24e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	9.15e-06	3.99e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	8.16e-06	3.56e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	7.78e-06	3.39e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	7.37e-06	3.21e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	6.87e-06	2.99e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	5.57e-06	2.43e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	5.5e-06	2.39e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	5.47e-06	2.38e-05	CbGpPWpGaD
